Silimed medical devices have regulatory certificate suspended

The Medicines and Healthcare products Regulatory Agency (MHRA) has suspended the CE certificate for all medical devices made by Brazilian manufacturer Silimed.

A CE mark is applied by the manufacturer and means that the device meets the relevant regulatory requirements and, when used as intended, works properly and is acceptably safe.

The devices covered by the suspended CE certificate include:

  • silicone implants for general and plastic surgery
  • gastric bands and balloons
  • implants for urology 

The MHRA is investigating the matter in collaboration with other European regulators and recommends that none of these devices should be implanted until further advice is issued. EU health regulators have initiated testing of samples of products to establish if there are any health risks.

At Spire Healthcare, we are reviewing our systems to identify how many of the potentially affected products have been supplied to us, and when and where these were used.  Until the investigation is complete, Spire Healthcare’s use of Silimed implants remains on hold.

The MHRA emphasises that for the moment there has been no indication that these issues would pose a threat to patient safety, but if you are worried about a procedure that you have had at a Spire hospital, please contact the hospital direct.

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

The latest health news

Visit our Health News section for the latest in healthcare news and medical research from the UK and abroad.

© Spire Healthcare Group plc (2016)